Global Hereditary Transthyretin Amyloidosis (Hattr) Market Research Report 2026(Status and Outlook)
Hereditary Transthyretin Amyloidosis (HATTR) is caused by the misfolding of protein monomers derived from the tetrameric protein transthyretin (TTR). Mutations in the gene for TTR frequently result in instability of TTR and subsequent fibril formation. HATTR can be sub-classified into familial amyloid polyneuropathy (FAP) and familial amyloid cardiomyopathy (FAC). The deposition of TTR amyloid fibrils in various tissues leads to ATTR, including Familial ATTR (hereditary ATTR) and non-hereditary ATTR types. Familial ATTR is a rare disorder with unequal distribution all around the world.
The global Hereditary Transthyretin Amyloidosis (Hattr) market size was estimated at USD 1240.5 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 12.45% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Hereditary Transthyretin Amyloidosis (Hattr) market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Hereditary Transthyretin Amyloidosis (Hattr) market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Hereditary Transthyretin Amyloidosis (Hattr) market.
Global Hereditary Transthyretin Amyloidosis (Hattr) Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Pfizer
Alnylam Pharmaceuticals
Akcea Therapeutics
Prothena
Lonis Pharmaceuticals
Eidos Therapeutics
Corino Therapeutics Inc
Market Segmentation (by Type)
Oral
Subcutaneous Injection
Others
Market Segmentation (by Application)
Hospital
Clinic
Others
Geographic Segmentation
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hereditary Transthyretin Amyloidosis (Hattr) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Hereditary Transthyretin Amyloidosis (Hattr), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Hereditary Transthyretin Amyloidosis (Hattr) market size was estimated at USD 1240.5 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 12.45% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Hereditary Transthyretin Amyloidosis (Hattr) market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Hereditary Transthyretin Amyloidosis (Hattr) market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Hereditary Transthyretin Amyloidosis (Hattr) market.
Global Hereditary Transthyretin Amyloidosis (Hattr) Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Pfizer
Alnylam Pharmaceuticals
Akcea Therapeutics
Prothena
Lonis Pharmaceuticals
Eidos Therapeutics
Corino Therapeutics Inc
Market Segmentation (by Type)
Oral
Subcutaneous Injection
Others
Market Segmentation (by Application)
Hospital
Clinic
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Hereditary Transthyretin Amyloidosis (Hattr) Market
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hereditary Transthyretin Amyloidosis (Hattr) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Hereditary Transthyretin Amyloidosis (Hattr), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Hereditary Transthyretin Amyloidosis (Hattr)
1.2 Key Market Segments
1.2.1 Hereditary Transthyretin Amyloidosis (Hattr) Segment by Type
1.2.2 Hereditary Transthyretin Amyloidosis (Hattr) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HEREDITARY TRANSTHYRETIN AMYLOIDOSIS (HATTR) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Hereditary Transthyretin Amyloidosis (Hattr) Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HEREDITARY TRANSTHYRETIN AMYLOIDOSIS (HATTR) MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Hereditary Transthyretin Amyloidosis (Hattr) Product Life Cycle
3.3 Global Hereditary Transthyretin Amyloidosis (Hattr) Sales by Manufacturers (2020-2025)
3.4 Global Hereditary Transthyretin Amyloidosis (Hattr) Revenue Market Share by Manufacturers (2020-2025)
3.5 Hereditary Transthyretin Amyloidosis (Hattr) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Hereditary Transthyretin Amyloidosis (Hattr) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Hereditary Transthyretin Amyloidosis (Hattr) Market Competitive Situation and Trends
3.8.1 Hereditary Transthyretin Amyloidosis (Hattr) Market Concentration Rate
3.8.2 Global 5 and 10 Largest Hereditary Transthyretin Amyloidosis (Hattr) Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 HEREDITARY TRANSTHYRETIN AMYLOIDOSIS (HATTR) INDUSTRY CHAIN ANALYSIS
4.1 Hereditary Transthyretin Amyloidosis (Hattr) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HEREDITARY TRANSTHYRETIN AMYLOIDOSIS (HATTR) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Hereditary Transthyretin Amyloidosis (Hattr) Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Hereditary Transthyretin Amyloidosis (Hattr) Market
5.7 ESG Ratings of Leading Companies
6 HEREDITARY TRANSTHYRETIN AMYLOIDOSIS (HATTR) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hereditary Transthyretin Amyloidosis (Hattr) Sales Market Share by Type (2020-2025)
6.3 Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Type (2020-2025)
6.4 Global Hereditary Transthyretin Amyloidosis (Hattr) Price by Type (2020-2025)
7 HEREDITARY TRANSTHYRETIN AMYLOIDOSIS (HATTR) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hereditary Transthyretin Amyloidosis (Hattr) Market Sales by Application (2020-2025)
7.3 Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size (M USD) by Application (2020-2025)
7.4 Global Hereditary Transthyretin Amyloidosis (Hattr) Sales Growth Rate by Application (2020-2025)
8 HEREDITARY TRANSTHYRETIN AMYLOIDOSIS (HATTR) MARKET SALES BY REGION
8.1 Global Hereditary Transthyretin Amyloidosis (Hattr) Sales by Region
8.1.1 Global Hereditary Transthyretin Amyloidosis (Hattr) Sales by Region
8.1.2 Global Hereditary Transthyretin Amyloidosis (Hattr) Sales Market Share by Region
8.2 Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Region
8.2.1 Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Region
8.2.2 Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Region
8.3 North America
8.3.1 North America Hereditary Transthyretin Amyloidosis (Hattr) Sales by Country
8.3.2 North America Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Hereditary Transthyretin Amyloidosis (Hattr) Sales by Country
8.4.2 Europe Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Hereditary Transthyretin Amyloidosis (Hattr) Sales by Region
8.5.2 Asia Pacific Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Hereditary Transthyretin Amyloidosis (Hattr) Sales by Country
8.6.2 South America Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Hereditary Transthyretin Amyloidosis (Hattr) Sales by Region
8.7.2 Middle East and Africa Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 HEREDITARY TRANSTHYRETIN AMYLOIDOSIS (HATTR) MARKET PRODUCTION BY REGION
9.1 Global Production of Hereditary Transthyretin Amyloidosis (Hattr) by Region(2020-2025)
9.2 Global Hereditary Transthyretin Amyloidosis (Hattr) Revenue Market Share by Region (2020-2025)
9.3 Global Hereditary Transthyretin Amyloidosis (Hattr) Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Hereditary Transthyretin Amyloidosis (Hattr) Production
9.4.1 North America Hereditary Transthyretin Amyloidosis (Hattr) Production Growth Rate (2020-2025)
9.4.2 North America Hereditary Transthyretin Amyloidosis (Hattr) Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Hereditary Transthyretin Amyloidosis (Hattr) Production
9.5.1 Europe Hereditary Transthyretin Amyloidosis (Hattr) Production Growth Rate (2020-2025)
9.5.2 Europe Hereditary Transthyretin Amyloidosis (Hattr) Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Hereditary Transthyretin Amyloidosis (Hattr) Production (2020-2025)
9.6.1 Japan Hereditary Transthyretin Amyloidosis (Hattr) Production Growth Rate (2020-2025)
9.6.2 Japan Hereditary Transthyretin Amyloidosis (Hattr) Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Hereditary Transthyretin Amyloidosis (Hattr) Production (2020-2025)
9.7.1 China Hereditary Transthyretin Amyloidosis (Hattr) Production Growth Rate (2020-2025)
9.7.2 China Hereditary Transthyretin Amyloidosis (Hattr) Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Pfizer
10.1.1 Pfizer Basic Information
10.1.2 Pfizer Hereditary Transthyretin Amyloidosis (Hattr) Product Overview
10.1.3 Pfizer Hereditary Transthyretin Amyloidosis (Hattr) Product Market Performance
10.1.4 Pfizer Business Overview
10.1.5 Pfizer SWOT Analysis
10.1.6 Pfizer Recent Developments
10.2 Alnylam Pharmaceuticals
10.2.1 Alnylam Pharmaceuticals Basic Information
10.2.2 Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (Hattr) Product Overview
10.2.3 Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (Hattr) Product Market Performance
10.2.4 Alnylam Pharmaceuticals Business Overview
10.2.5 Alnylam Pharmaceuticals SWOT Analysis
10.2.6 Alnylam Pharmaceuticals Recent Developments
10.3 Akcea Therapeutics
10.3.1 Akcea Therapeutics Basic Information
10.3.2 Akcea Therapeutics Hereditary Transthyretin Amyloidosis (Hattr) Product Overview
10.3.3 Akcea Therapeutics Hereditary Transthyretin Amyloidosis (Hattr) Product Market Performance
10.3.4 Akcea Therapeutics Business Overview
10.3.5 Akcea Therapeutics SWOT Analysis
10.3.6 Akcea Therapeutics Recent Developments
10.4 Prothena
10.4.1 Prothena Basic Information
10.4.2 Prothena Hereditary Transthyretin Amyloidosis (Hattr) Product Overview
10.4.3 Prothena Hereditary Transthyretin Amyloidosis (Hattr) Product Market Performance
10.4.4 Prothena Business Overview
10.4.5 Prothena Recent Developments
10.5 Lonis Pharmaceuticals
10.5.1 Lonis Pharmaceuticals Basic Information
10.5.2 Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (Hattr) Product Overview
10.5.3 Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (Hattr) Product Market Performance
10.5.4 Lonis Pharmaceuticals Business Overview
10.5.5 Lonis Pharmaceuticals Recent Developments
10.6 Eidos Therapeutics
10.6.1 Eidos Therapeutics Basic Information
10.6.2 Eidos Therapeutics Hereditary Transthyretin Amyloidosis (Hattr) Product Overview
10.6.3 Eidos Therapeutics Hereditary Transthyretin Amyloidosis (Hattr) Product Market Performance
10.6.4 Eidos Therapeutics Business Overview
10.6.5 Eidos Therapeutics Recent Developments
10.7 Corino Therapeutics Inc
10.7.1 Corino Therapeutics Inc Basic Information
10.7.2 Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (Hattr) Product Overview
10.7.3 Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (Hattr) Product Market Performance
10.7.4 Corino Therapeutics Inc Business Overview
10.7.5 Corino Therapeutics Inc Recent Developments
11 HEREDITARY TRANSTHYRETIN AMYLOIDOSIS (HATTR) MARKET FORECAST BY REGION
11.1 Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size Forecast
11.2 Global Hereditary Transthyretin Amyloidosis (Hattr) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Hereditary Transthyretin Amyloidosis (Hattr) Market Size Forecast by Country
11.2.3 Asia Pacific Hereditary Transthyretin Amyloidosis (Hattr) Market Size Forecast by Region
11.2.4 South America Hereditary Transthyretin Amyloidosis (Hattr) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Hereditary Transthyretin Amyloidosis (Hattr) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Hereditary Transthyretin Amyloidosis (Hattr) Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Hereditary Transthyretin Amyloidosis (Hattr) by Type (2026-2035)
12.1.2 Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Hereditary Transthyretin Amyloidosis (Hattr) by Type (2026-2035)
12.2 Global Hereditary Transthyretin Amyloidosis (Hattr) Market Forecast by Application (2026-2035)
12.2.1 Global Hereditary Transthyretin Amyloidosis (Hattr) Sales (K Units) Forecast by Application
12.2.2 Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Hereditary Transthyretin Amyloidosis (Hattr)
1.2 Key Market Segments
1.2.1 Hereditary Transthyretin Amyloidosis (Hattr) Segment by Type
1.2.2 Hereditary Transthyretin Amyloidosis (Hattr) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HEREDITARY TRANSTHYRETIN AMYLOIDOSIS (HATTR) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Hereditary Transthyretin Amyloidosis (Hattr) Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HEREDITARY TRANSTHYRETIN AMYLOIDOSIS (HATTR) MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Hereditary Transthyretin Amyloidosis (Hattr) Product Life Cycle
3.3 Global Hereditary Transthyretin Amyloidosis (Hattr) Sales by Manufacturers (2020-2025)
3.4 Global Hereditary Transthyretin Amyloidosis (Hattr) Revenue Market Share by Manufacturers (2020-2025)
3.5 Hereditary Transthyretin Amyloidosis (Hattr) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Hereditary Transthyretin Amyloidosis (Hattr) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Hereditary Transthyretin Amyloidosis (Hattr) Market Competitive Situation and Trends
3.8.1 Hereditary Transthyretin Amyloidosis (Hattr) Market Concentration Rate
3.8.2 Global 5 and 10 Largest Hereditary Transthyretin Amyloidosis (Hattr) Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 HEREDITARY TRANSTHYRETIN AMYLOIDOSIS (HATTR) INDUSTRY CHAIN ANALYSIS
4.1 Hereditary Transthyretin Amyloidosis (Hattr) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HEREDITARY TRANSTHYRETIN AMYLOIDOSIS (HATTR) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Hereditary Transthyretin Amyloidosis (Hattr) Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Hereditary Transthyretin Amyloidosis (Hattr) Market
5.7 ESG Ratings of Leading Companies
6 HEREDITARY TRANSTHYRETIN AMYLOIDOSIS (HATTR) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hereditary Transthyretin Amyloidosis (Hattr) Sales Market Share by Type (2020-2025)
6.3 Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Type (2020-2025)
6.4 Global Hereditary Transthyretin Amyloidosis (Hattr) Price by Type (2020-2025)
7 HEREDITARY TRANSTHYRETIN AMYLOIDOSIS (HATTR) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hereditary Transthyretin Amyloidosis (Hattr) Market Sales by Application (2020-2025)
7.3 Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size (M USD) by Application (2020-2025)
7.4 Global Hereditary Transthyretin Amyloidosis (Hattr) Sales Growth Rate by Application (2020-2025)
8 HEREDITARY TRANSTHYRETIN AMYLOIDOSIS (HATTR) MARKET SALES BY REGION
8.1 Global Hereditary Transthyretin Amyloidosis (Hattr) Sales by Region
8.1.1 Global Hereditary Transthyretin Amyloidosis (Hattr) Sales by Region
8.1.2 Global Hereditary Transthyretin Amyloidosis (Hattr) Sales Market Share by Region
8.2 Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Region
8.2.1 Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Region
8.2.2 Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Region
8.3 North America
8.3.1 North America Hereditary Transthyretin Amyloidosis (Hattr) Sales by Country
8.3.2 North America Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Hereditary Transthyretin Amyloidosis (Hattr) Sales by Country
8.4.2 Europe Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Hereditary Transthyretin Amyloidosis (Hattr) Sales by Region
8.5.2 Asia Pacific Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Hereditary Transthyretin Amyloidosis (Hattr) Sales by Country
8.6.2 South America Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Hereditary Transthyretin Amyloidosis (Hattr) Sales by Region
8.7.2 Middle East and Africa Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 HEREDITARY TRANSTHYRETIN AMYLOIDOSIS (HATTR) MARKET PRODUCTION BY REGION
9.1 Global Production of Hereditary Transthyretin Amyloidosis (Hattr) by Region(2020-2025)
9.2 Global Hereditary Transthyretin Amyloidosis (Hattr) Revenue Market Share by Region (2020-2025)
9.3 Global Hereditary Transthyretin Amyloidosis (Hattr) Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Hereditary Transthyretin Amyloidosis (Hattr) Production
9.4.1 North America Hereditary Transthyretin Amyloidosis (Hattr) Production Growth Rate (2020-2025)
9.4.2 North America Hereditary Transthyretin Amyloidosis (Hattr) Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Hereditary Transthyretin Amyloidosis (Hattr) Production
9.5.1 Europe Hereditary Transthyretin Amyloidosis (Hattr) Production Growth Rate (2020-2025)
9.5.2 Europe Hereditary Transthyretin Amyloidosis (Hattr) Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Hereditary Transthyretin Amyloidosis (Hattr) Production (2020-2025)
9.6.1 Japan Hereditary Transthyretin Amyloidosis (Hattr) Production Growth Rate (2020-2025)
9.6.2 Japan Hereditary Transthyretin Amyloidosis (Hattr) Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Hereditary Transthyretin Amyloidosis (Hattr) Production (2020-2025)
9.7.1 China Hereditary Transthyretin Amyloidosis (Hattr) Production Growth Rate (2020-2025)
9.7.2 China Hereditary Transthyretin Amyloidosis (Hattr) Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Pfizer
10.1.1 Pfizer Basic Information
10.1.2 Pfizer Hereditary Transthyretin Amyloidosis (Hattr) Product Overview
10.1.3 Pfizer Hereditary Transthyretin Amyloidosis (Hattr) Product Market Performance
10.1.4 Pfizer Business Overview
10.1.5 Pfizer SWOT Analysis
10.1.6 Pfizer Recent Developments
10.2 Alnylam Pharmaceuticals
10.2.1 Alnylam Pharmaceuticals Basic Information
10.2.2 Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (Hattr) Product Overview
10.2.3 Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (Hattr) Product Market Performance
10.2.4 Alnylam Pharmaceuticals Business Overview
10.2.5 Alnylam Pharmaceuticals SWOT Analysis
10.2.6 Alnylam Pharmaceuticals Recent Developments
10.3 Akcea Therapeutics
10.3.1 Akcea Therapeutics Basic Information
10.3.2 Akcea Therapeutics Hereditary Transthyretin Amyloidosis (Hattr) Product Overview
10.3.3 Akcea Therapeutics Hereditary Transthyretin Amyloidosis (Hattr) Product Market Performance
10.3.4 Akcea Therapeutics Business Overview
10.3.5 Akcea Therapeutics SWOT Analysis
10.3.6 Akcea Therapeutics Recent Developments
10.4 Prothena
10.4.1 Prothena Basic Information
10.4.2 Prothena Hereditary Transthyretin Amyloidosis (Hattr) Product Overview
10.4.3 Prothena Hereditary Transthyretin Amyloidosis (Hattr) Product Market Performance
10.4.4 Prothena Business Overview
10.4.5 Prothena Recent Developments
10.5 Lonis Pharmaceuticals
10.5.1 Lonis Pharmaceuticals Basic Information
10.5.2 Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (Hattr) Product Overview
10.5.3 Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (Hattr) Product Market Performance
10.5.4 Lonis Pharmaceuticals Business Overview
10.5.5 Lonis Pharmaceuticals Recent Developments
10.6 Eidos Therapeutics
10.6.1 Eidos Therapeutics Basic Information
10.6.2 Eidos Therapeutics Hereditary Transthyretin Amyloidosis (Hattr) Product Overview
10.6.3 Eidos Therapeutics Hereditary Transthyretin Amyloidosis (Hattr) Product Market Performance
10.6.4 Eidos Therapeutics Business Overview
10.6.5 Eidos Therapeutics Recent Developments
10.7 Corino Therapeutics Inc
10.7.1 Corino Therapeutics Inc Basic Information
10.7.2 Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (Hattr) Product Overview
10.7.3 Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (Hattr) Product Market Performance
10.7.4 Corino Therapeutics Inc Business Overview
10.7.5 Corino Therapeutics Inc Recent Developments
11 HEREDITARY TRANSTHYRETIN AMYLOIDOSIS (HATTR) MARKET FORECAST BY REGION
11.1 Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size Forecast
11.2 Global Hereditary Transthyretin Amyloidosis (Hattr) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Hereditary Transthyretin Amyloidosis (Hattr) Market Size Forecast by Country
11.2.3 Asia Pacific Hereditary Transthyretin Amyloidosis (Hattr) Market Size Forecast by Region
11.2.4 South America Hereditary Transthyretin Amyloidosis (Hattr) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Hereditary Transthyretin Amyloidosis (Hattr) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Hereditary Transthyretin Amyloidosis (Hattr) Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Hereditary Transthyretin Amyloidosis (Hattr) by Type (2026-2035)
12.1.2 Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Hereditary Transthyretin Amyloidosis (Hattr) by Type (2026-2035)
12.2 Global Hereditary Transthyretin Amyloidosis (Hattr) Market Forecast by Application (2026-2035)
12.2.1 Global Hereditary Transthyretin Amyloidosis (Hattr) Sales (K Units) Forecast by Application
12.2.2 Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Type (M USD)
Table 4. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Application
Table 5. Hereditary Transthyretin Amyloidosis (Hattr) Market Size Comparison by Region (M USD)
Table 6. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Hereditary Transthyretin Amyloidosis (Hattr) Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Hereditary Transthyretin Amyloidosis (Hattr) Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Transthyretin Amyloidosis (Hattr) as of 2025)
Table 11. Global Market Hereditary Transthyretin Amyloidosis (Hattr) Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Hereditary Transthyretin Amyloidosis (Hattr) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Hereditary Transthyretin Amyloidosis (Hattr) Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales by Type (K Units)
Table 27. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Type (M USD)
Table 28. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales (K Units) by Type (2020-2025)
Table 29. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales Market Share by Type (2020-2025)
Table 30. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size (M USD) by Type (2020-2025)
Table 31. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Share by Type (2020-2025)
Table 32. Global Hereditary Transthyretin Amyloidosis (Hattr) Price (USD/Unit) by Type (2020-2025)
Table 33. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales (K Units) by Application
Table 34. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Application
Table 35. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales by Application (2020-2025) & (K Units)
Table 36. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales Market Share by Application (2020-2025)
Table 37. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Application (2020-2025) & (M USD)
Table 38. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Share by Application (2020-2025)
Table 39. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales Growth Rate by Application (2020-2025)
Table 40. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales by Region (2020-2025) & (K Units)
Table 41. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales Market Share by Region (2020-2025)
Table 42. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Region (2020-2025) & (M USD)
Table 43. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Region (2020-2025)
Table 44. North America Hereditary Transthyretin Amyloidosis (Hattr) Sales by Country (2020-2025) & (K Units)
Table 45. North America Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Hereditary Transthyretin Amyloidosis (Hattr) Sales by Country (2020-2025) & (K Units)
Table 47. Europe Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Hereditary Transthyretin Amyloidosis (Hattr) Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Region (2020-2025) & (M USD)
Table 50. South America Hereditary Transthyretin Amyloidosis (Hattr) Sales by Country (2020-2025) & (K Units)
Table 51. South America Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Hereditary Transthyretin Amyloidosis (Hattr) Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Region (2020-2025) & (M USD)
Table 54. Global Hereditary Transthyretin Amyloidosis (Hattr) Production (K Units) by Region(2020-2025)
Table 55. Global Hereditary Transthyretin Amyloidosis (Hattr) Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Hereditary Transthyretin Amyloidosis (Hattr) Revenue Market Share by Region (2020-2025)
Table 57. Global Hereditary Transthyretin Amyloidosis (Hattr) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Hereditary Transthyretin Amyloidosis (Hattr) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Hereditary Transthyretin Amyloidosis (Hattr) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Hereditary Transthyretin Amyloidosis (Hattr) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Hereditary Transthyretin Amyloidosis (Hattr) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Pfizer Basic Information
Table 63. Pfizer Hereditary Transthyretin Amyloidosis (Hattr) Product Overview
Table 64. Pfizer Hereditary Transthyretin Amyloidosis (Hattr) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Pfizer Business Overview
Table 66. Pfizer SWOT Analysis
Table 67. Pfizer Recent Developments
Table 68. Alnylam Pharmaceuticals Basic Information
Table 69. Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (Hattr) Product Overview
Table 70. Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (Hattr) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Alnylam Pharmaceuticals Business Overview
Table 72. Alnylam Pharmaceuticals SWOT Analysis
Table 73. Alnylam Pharmaceuticals Recent Developments
Table 74. Akcea Therapeutics Basic Information
Table 75. Akcea Therapeutics Hereditary Transthyretin Amyloidosis (Hattr) Product Overview
Table 76. Akcea Therapeutics Hereditary Transthyretin Amyloidosis (Hattr) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Akcea Therapeutics Business Overview
Table 78. Akcea Therapeutics SWOT Analysis
Table 79. Akcea Therapeutics Recent Developments
Table 80. Prothena Basic Information
Table 81. Prothena Hereditary Transthyretin Amyloidosis (Hattr) Product Overview
Table 82. Prothena Hereditary Transthyretin Amyloidosis (Hattr) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Prothena Business Overview
Table 84. Prothena Recent Developments
Table 85. Lonis Pharmaceuticals Basic Information
Table 86. Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (Hattr) Product Overview
Table 87. Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (Hattr) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Lonis Pharmaceuticals Business Overview
Table 89. Lonis Pharmaceuticals Recent Developments
Table 90. Eidos Therapeutics Basic Information
Table 91. Eidos Therapeutics Hereditary Transthyretin Amyloidosis (Hattr) Product Overview
Table 92. Eidos Therapeutics Hereditary Transthyretin Amyloidosis (Hattr) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Eidos Therapeutics Business Overview
Table 94. Eidos Therapeutics Recent Developments
Table 95. Corino Therapeutics Inc Basic Information
Table 96. Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (Hattr) Product Overview
Table 97. Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (Hattr) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Corino Therapeutics Inc Business Overview
Table 99. Corino Therapeutics Inc Recent Developments
Table 100. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales Forecast by Region (2026-2035) & (K Units)
Table 101. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size Forecast by Region (2026-2035) & (M USD)
Table 102. North America Hereditary Transthyretin Amyloidosis (Hattr) Sales Forecast by Country (2026-2035) & (K Units)
Table 103. North America Hereditary Transthyretin Amyloidosis (Hattr) Market Size Forecast by Country (2026-2035) & (M USD)
Table 104. Europe Hereditary Transthyretin Amyloidosis (Hattr) Sales Forecast by Country (2026-2035) & (K Units)
Table 105. Europe Hereditary Transthyretin Amyloidosis (Hattr) Market Size Forecast by Country (2026-2035) & (M USD)
Table 106. Asia Pacific Hereditary Transthyretin Amyloidosis (Hattr) Sales Forecast by Region (2026-2035) & (K Units)
Table 107. Asia Pacific Hereditary Transthyretin Amyloidosis (Hattr) Market Size Forecast by Region (2026-2035) & (M USD)
Table 108. South America Hereditary Transthyretin Amyloidosis (Hattr) Sales Forecast by Country (2026-2035) & (K Units)
Table 109. South America Hereditary Transthyretin Amyloidosis (Hattr) Market Size Forecast by Country (2026-2035) & (M USD)
Table 110. Middle East and Africa Hereditary Transthyretin Amyloidosis (Hattr) Sales Forecast by Country (2026-2035) & (Units)
Table 111. Middle East and Africa Hereditary Transthyretin Amyloidosis (Hattr) Market Size Forecast by Country (2026-2035) & (M USD)
Table 112. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales Forecast by Type (2026-2035) & (K Units)
Table 113. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size Forecast by Type (2026-2035) & (M USD)
Table 114. Global Hereditary Transthyretin Amyloidosis (Hattr) Price Forecast by Type (2026-2035) & (USD/Unit)
Table 115. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales (K Units) Forecast by Application (2026-2035)
Table 116. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Type (M USD)
Table 4. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Application
Table 5. Hereditary Transthyretin Amyloidosis (Hattr) Market Size Comparison by Region (M USD)
Table 6. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Hereditary Transthyretin Amyloidosis (Hattr) Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Hereditary Transthyretin Amyloidosis (Hattr) Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Transthyretin Amyloidosis (Hattr) as of 2025)
Table 11. Global Market Hereditary Transthyretin Amyloidosis (Hattr) Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Hereditary Transthyretin Amyloidosis (Hattr) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Hereditary Transthyretin Amyloidosis (Hattr) Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales by Type (K Units)
Table 27. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Type (M USD)
Table 28. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales (K Units) by Type (2020-2025)
Table 29. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales Market Share by Type (2020-2025)
Table 30. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size (M USD) by Type (2020-2025)
Table 31. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Share by Type (2020-2025)
Table 32. Global Hereditary Transthyretin Amyloidosis (Hattr) Price (USD/Unit) by Type (2020-2025)
Table 33. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales (K Units) by Application
Table 34. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Application
Table 35. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales by Application (2020-2025) & (K Units)
Table 36. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales Market Share by Application (2020-2025)
Table 37. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Application (2020-2025) & (M USD)
Table 38. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Share by Application (2020-2025)
Table 39. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales Growth Rate by Application (2020-2025)
Table 40. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales by Region (2020-2025) & (K Units)
Table 41. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales Market Share by Region (2020-2025)
Table 42. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Region (2020-2025) & (M USD)
Table 43. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Region (2020-2025)
Table 44. North America Hereditary Transthyretin Amyloidosis (Hattr) Sales by Country (2020-2025) & (K Units)
Table 45. North America Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Hereditary Transthyretin Amyloidosis (Hattr) Sales by Country (2020-2025) & (K Units)
Table 47. Europe Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Hereditary Transthyretin Amyloidosis (Hattr) Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Region (2020-2025) & (M USD)
Table 50. South America Hereditary Transthyretin Amyloidosis (Hattr) Sales by Country (2020-2025) & (K Units)
Table 51. South America Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Hereditary Transthyretin Amyloidosis (Hattr) Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Region (2020-2025) & (M USD)
Table 54. Global Hereditary Transthyretin Amyloidosis (Hattr) Production (K Units) by Region(2020-2025)
Table 55. Global Hereditary Transthyretin Amyloidosis (Hattr) Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Hereditary Transthyretin Amyloidosis (Hattr) Revenue Market Share by Region (2020-2025)
Table 57. Global Hereditary Transthyretin Amyloidosis (Hattr) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Hereditary Transthyretin Amyloidosis (Hattr) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Hereditary Transthyretin Amyloidosis (Hattr) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Hereditary Transthyretin Amyloidosis (Hattr) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Hereditary Transthyretin Amyloidosis (Hattr) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Pfizer Basic Information
Table 63. Pfizer Hereditary Transthyretin Amyloidosis (Hattr) Product Overview
Table 64. Pfizer Hereditary Transthyretin Amyloidosis (Hattr) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Pfizer Business Overview
Table 66. Pfizer SWOT Analysis
Table 67. Pfizer Recent Developments
Table 68. Alnylam Pharmaceuticals Basic Information
Table 69. Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (Hattr) Product Overview
Table 70. Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (Hattr) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Alnylam Pharmaceuticals Business Overview
Table 72. Alnylam Pharmaceuticals SWOT Analysis
Table 73. Alnylam Pharmaceuticals Recent Developments
Table 74. Akcea Therapeutics Basic Information
Table 75. Akcea Therapeutics Hereditary Transthyretin Amyloidosis (Hattr) Product Overview
Table 76. Akcea Therapeutics Hereditary Transthyretin Amyloidosis (Hattr) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Akcea Therapeutics Business Overview
Table 78. Akcea Therapeutics SWOT Analysis
Table 79. Akcea Therapeutics Recent Developments
Table 80. Prothena Basic Information
Table 81. Prothena Hereditary Transthyretin Amyloidosis (Hattr) Product Overview
Table 82. Prothena Hereditary Transthyretin Amyloidosis (Hattr) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Prothena Business Overview
Table 84. Prothena Recent Developments
Table 85. Lonis Pharmaceuticals Basic Information
Table 86. Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (Hattr) Product Overview
Table 87. Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (Hattr) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Lonis Pharmaceuticals Business Overview
Table 89. Lonis Pharmaceuticals Recent Developments
Table 90. Eidos Therapeutics Basic Information
Table 91. Eidos Therapeutics Hereditary Transthyretin Amyloidosis (Hattr) Product Overview
Table 92. Eidos Therapeutics Hereditary Transthyretin Amyloidosis (Hattr) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Eidos Therapeutics Business Overview
Table 94. Eidos Therapeutics Recent Developments
Table 95. Corino Therapeutics Inc Basic Information
Table 96. Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (Hattr) Product Overview
Table 97. Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (Hattr) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Corino Therapeutics Inc Business Overview
Table 99. Corino Therapeutics Inc Recent Developments
Table 100. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales Forecast by Region (2026-2035) & (K Units)
Table 101. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size Forecast by Region (2026-2035) & (M USD)
Table 102. North America Hereditary Transthyretin Amyloidosis (Hattr) Sales Forecast by Country (2026-2035) & (K Units)
Table 103. North America Hereditary Transthyretin Amyloidosis (Hattr) Market Size Forecast by Country (2026-2035) & (M USD)
Table 104. Europe Hereditary Transthyretin Amyloidosis (Hattr) Sales Forecast by Country (2026-2035) & (K Units)
Table 105. Europe Hereditary Transthyretin Amyloidosis (Hattr) Market Size Forecast by Country (2026-2035) & (M USD)
Table 106. Asia Pacific Hereditary Transthyretin Amyloidosis (Hattr) Sales Forecast by Region (2026-2035) & (K Units)
Table 107. Asia Pacific Hereditary Transthyretin Amyloidosis (Hattr) Market Size Forecast by Region (2026-2035) & (M USD)
Table 108. South America Hereditary Transthyretin Amyloidosis (Hattr) Sales Forecast by Country (2026-2035) & (K Units)
Table 109. South America Hereditary Transthyretin Amyloidosis (Hattr) Market Size Forecast by Country (2026-2035) & (M USD)
Table 110. Middle East and Africa Hereditary Transthyretin Amyloidosis (Hattr) Sales Forecast by Country (2026-2035) & (Units)
Table 111. Middle East and Africa Hereditary Transthyretin Amyloidosis (Hattr) Market Size Forecast by Country (2026-2035) & (M USD)
Table 112. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales Forecast by Type (2026-2035) & (K Units)
Table 113. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size Forecast by Type (2026-2035) & (M USD)
Table 114. Global Hereditary Transthyretin Amyloidosis (Hattr) Price Forecast by Type (2026-2035) & (USD/Unit)
Table 115. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales (K Units) Forecast by Application (2026-2035)
Table 116. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Hereditary Transthyretin Amyloidosis (Hattr)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size (M USD), 2025-2035
Figure 5. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size (M USD) (2020-2035)
Figure 6. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Hereditary Transthyretin Amyloidosis (Hattr) Product Life Cycle
Figure 13. Hereditary Transthyretin Amyloidosis (Hattr) Sales Share by Manufacturers in 2025
Figure 14. Global Hereditary Transthyretin Amyloidosis (Hattr) Revenue Share by Manufacturers in 2025
Figure 15. Hereditary Transthyretin Amyloidosis (Hattr) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Hereditary Transthyretin Amyloidosis (Hattr) Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Hereditary Transthyretin Amyloidosis (Hattr) Revenue in 2025
Figure 18. Industry Chain Map of Hereditary Transthyretin Amyloidosis (Hattr)
Figure 19. Global Hereditary Transthyretin Amyloidosis (Hattr) Market PEST Analysis
Figure 20. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Share by Type
Figure 27. Sales Market Share of Hereditary Transthyretin Amyloidosis (Hattr) by Type (2020-2025)
Figure 28. Sales Market Share of Hereditary Transthyretin Amyloidosis (Hattr) by Type in 2025
Figure 29. Market Share of Hereditary Transthyretin Amyloidosis (Hattr) by Type (2020-2025)
Figure 30. Market Share of Hereditary Transthyretin Amyloidosis (Hattr) by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Share by Application
Figure 33. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales Market Share by Application (2020-2025)
Figure 34. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales Market Share by Application in 2025
Figure 35. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Share by Application (2020-2025)
Figure 36. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Share by Application in 2025
Figure 37. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales Growth Rate by Application (2020-2025)
Figure 38. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales Market Share by Region (2020-2025)
Figure 39. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Region (2020-2025)
Figure 40. North America Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Hereditary Transthyretin Amyloidosis (Hattr) Sales Market Share by Country in 2024
Figure 43. North America Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Country in 2024
Figure 45. U.S. Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Hereditary Transthyretin Amyloidosis (Hattr) Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Hereditary Transthyretin Amyloidosis (Hattr) Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Hereditary Transthyretin Amyloidosis (Hattr) Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Hereditary Transthyretin Amyloidosis (Hattr) Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Hereditary Transthyretin Amyloidosis (Hattr) Sales Market Share by Country in 2024
Figure 53. Europe Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Country in 2024
Figure 55. Germany Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Hereditary Transthyretin Amyloidosis (Hattr) Sales Market Share by Region in 2024
Figure 67. Asia Pacific Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Region in 2024
Figure 68. China Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (K Units)
Figure 79. South America Hereditary Transthyretin Amyloidosis (Hattr) Sales Market Share by Country in 2024
Figure 80. South America Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (M USD)
Figure 81. South America Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Country in 2024
Figure 82. Brazil Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Hereditary Transthyretin Amyloidosis (Hattr) Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Region in 2024
Figure 92. Saudi Arabia Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Hereditary Transthyretin Amyloidosis (Hattr) Production Market Share by Region (2020-2025)
Figure 103. North America Hereditary Transthyretin Amyloidosis (Hattr) Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Hereditary Transthyretin Amyloidosis (Hattr) Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Hereditary Transthyretin Amyloidosis (Hattr) Production (K Units) Growth Rate (2020-2025)
Figure 106. China Hereditary Transthyretin Amyloidosis (Hattr) Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Share Forecast by Type (2026-2035)
Figure 111. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales Forecast by Application (2026-2035)
Figure 112. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Hereditary Transthyretin Amyloidosis (Hattr)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size (M USD), 2025-2035
Figure 5. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size (M USD) (2020-2035)
Figure 6. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Hereditary Transthyretin Amyloidosis (Hattr) Product Life Cycle
Figure 13. Hereditary Transthyretin Amyloidosis (Hattr) Sales Share by Manufacturers in 2025
Figure 14. Global Hereditary Transthyretin Amyloidosis (Hattr) Revenue Share by Manufacturers in 2025
Figure 15. Hereditary Transthyretin Amyloidosis (Hattr) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Hereditary Transthyretin Amyloidosis (Hattr) Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Hereditary Transthyretin Amyloidosis (Hattr) Revenue in 2025
Figure 18. Industry Chain Map of Hereditary Transthyretin Amyloidosis (Hattr)
Figure 19. Global Hereditary Transthyretin Amyloidosis (Hattr) Market PEST Analysis
Figure 20. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Share by Type
Figure 27. Sales Market Share of Hereditary Transthyretin Amyloidosis (Hattr) by Type (2020-2025)
Figure 28. Sales Market Share of Hereditary Transthyretin Amyloidosis (Hattr) by Type in 2025
Figure 29. Market Share of Hereditary Transthyretin Amyloidosis (Hattr) by Type (2020-2025)
Figure 30. Market Share of Hereditary Transthyretin Amyloidosis (Hattr) by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Share by Application
Figure 33. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales Market Share by Application (2020-2025)
Figure 34. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales Market Share by Application in 2025
Figure 35. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Share by Application (2020-2025)
Figure 36. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Share by Application in 2025
Figure 37. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales Growth Rate by Application (2020-2025)
Figure 38. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales Market Share by Region (2020-2025)
Figure 39. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Region (2020-2025)
Figure 40. North America Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Hereditary Transthyretin Amyloidosis (Hattr) Sales Market Share by Country in 2024
Figure 43. North America Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Country in 2024
Figure 45. U.S. Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Hereditary Transthyretin Amyloidosis (Hattr) Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Hereditary Transthyretin Amyloidosis (Hattr) Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Hereditary Transthyretin Amyloidosis (Hattr) Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Hereditary Transthyretin Amyloidosis (Hattr) Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Hereditary Transthyretin Amyloidosis (Hattr) Sales Market Share by Country in 2024
Figure 53. Europe Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Country in 2024
Figure 55. Germany Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Hereditary Transthyretin Amyloidosis (Hattr) Sales Market Share by Region in 2024
Figure 67. Asia Pacific Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Region in 2024
Figure 68. China Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (K Units)
Figure 79. South America Hereditary Transthyretin Amyloidosis (Hattr) Sales Market Share by Country in 2024
Figure 80. South America Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (M USD)
Figure 81. South America Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Country in 2024
Figure 82. Brazil Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Hereditary Transthyretin Amyloidosis (Hattr) Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Hereditary Transthyretin Amyloidosis (Hattr) Market Size by Region in 2024
Figure 92. Saudi Arabia Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Hereditary Transthyretin Amyloidosis (Hattr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Hereditary Transthyretin Amyloidosis (Hattr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Hereditary Transthyretin Amyloidosis (Hattr) Production Market Share by Region (2020-2025)
Figure 103. North America Hereditary Transthyretin Amyloidosis (Hattr) Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Hereditary Transthyretin Amyloidosis (Hattr) Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Hereditary Transthyretin Amyloidosis (Hattr) Production (K Units) Growth Rate (2020-2025)
Figure 106. China Hereditary Transthyretin Amyloidosis (Hattr) Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Share Forecast by Type (2026-2035)
Figure 111. Global Hereditary Transthyretin Amyloidosis (Hattr) Sales Forecast by Application (2026-2035)
Figure 112. Global Hereditary Transthyretin Amyloidosis (Hattr) Market Share Forecast by Application (2026-2035)
